Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands

被引:10
作者
Vos, Cornelis F. [1 ,2 ]
Aarnoutse, Rob E. [3 ]
Op de Coul, Marijke J. M. [4 ]
Spijker, Jan [4 ,5 ]
Groothedde-Kuyvenhoven, Mascha M. [6 ,7 ]
Mihaescu, Raluca [8 ]
Wessels-Basten, Sonja J. W. [8 ]
Rovers, Jordy J. E. [9 ]
ter Hark, Sophie E. [1 ,2 ]
Schene, Aart H. [1 ,2 ]
Hulscher, Marlies E. J. L. [10 ]
Janzing, Joost G. E. [1 ,2 ]
机构
[1] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, Reinier Postlaan 10, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Pharm Radboud Inst Hlth Sci, Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Nijmegen, Netherlands
[5] Pro Persona, Nijmegen, Netherlands
[6] Deventer Hosp, Deventer, Netherlands
[7] Dimence Grp, Deventer, Netherlands
[8] Catharina Hosp, Eindhoven, Netherlands
[9] Vincent van Gogh Inst Psychiat, Venray, Netherlands
[10] Radboud Univ Nijmegen, Sci Ctr Qual Hlthcare, Med Ctr, Nijmegen, Netherlands
关键词
Antidepressant agents; Clinical practice guidelines; Qualitative approach; Major depressive disorder; Tricyclic antidepressants; GUIDELINES;
D O I
10.1186/s12888-021-03490-x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Traditionally tricyclic antidepressants (TCAs) have an important place in treatment of major depressive disorder (MDD). Today, often other antidepressant medications are considered as first step in the pharmacological treatment of MDD, mainly because they are associated with less adverse effects, whereby the position of TCAs appears unclear. In this study we aimed to examine the current practice of TCAs in treatment of unipolar MDD. Methods A mixed methods approach was applied. First, a selection of leading international and national guidelines was reviewed. Second, actual TCA prescription was examined by analyzing health records of 75 MDD patients treated with the TCAs nortriptyline, clomipramine or imipramine in different centers in the Netherlands. Third, promotors and barriers influencing the choice for TCAs and dosing strategies were explored using semi-structured interviews with 24 Dutch psychiatrists. Results Clinical practice guidelines were sometimes indirective and inconsistent with each other. Health records revealed that most patients (71%) attained therapeutic plasma concentrations within two months of TCA use. Patients who achieved therapeutic plasma concentrations reached them on average after 19.6 days (SD 10.9). Both health records and interviews indicated that therapeutic nortriptyline concentrations were attained faster compared to other TCAs. Various factors were identified influencing the choice for TCAs and dosing by psychiatrists. Conclusions Guideline recommendations and clinical practice regarding TCA prescription for MDD vary. To increase consistency in clinical practice we recommend development of an up-to-date guideline integrating selection and dosing of TCAs, including the roles of therapeutic drug monitoring and pharmacogenetics. Such a guideline is currently lacking and would contribute to optimal TCA treatment, whereby efficacy and tolerability may be increased.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands
    Cornelis F. Vos
    Rob E. Aarnoutse
    Marijke J. M. Op de Coul
    Jan Spijker
    Mascha M. Groothedde-Kuyvenhoven
    Raluca Mihaescu
    Sonja J. W. Wessels-Basten
    Jordy J. E. Rovers
    Sophie E. ter Hark
    Aart H. Schene
    Marlies E. J. L. Hulscher
    Joost G. E. Janzing
    BMC Psychiatry, 21
  • [2] Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic review
    Hark, Sophie E. ter
    Vos, Cornelis F.
    Aarnoutse, Rob E.
    Schene, Aart H.
    Coenen, Marieke J. H.
    Janzing, Joost G. E.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 150 : 202 - 213
  • [3] FLUOXETINE IN TRICYCLIC REFRACTORY MAJOR DEPRESSIVE DISORDER
    BEASLEY, CM
    SAYLER, ME
    CUNNINGHAM, GE
    WEISS, AM
    MASICA, DN
    JOURNAL OF AFFECTIVE DISORDERS, 1990, 20 (03) : 193 - 200
  • [4] Emerging antidepressants to treat major depressive disorder
    Block, Samantha G.
    Nemeroff, Charles B.
    ASIAN JOURNAL OF PSYCHIATRY, 2014, 12 : 7 - 16
  • [5] Tricyclic antidepressants versus 'active placebo', placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
    Jorgensen, Caroline Kamp
    Juul, Sophie
    Siddiqui, Faiza
    Barbateskovic, Marija
    Munkholm, Klaus
    Hengartner, Michael Pascal
    Kirsch, Irving
    Gluud, Christian
    Jakobsen, Janus Christian
    SYSTEMATIC REVIEWS, 2021, 10 (01)
  • [6] Orosomucoid influences the response to antidepressants in major depressive disorder
    Harley, J.
    Roberts, R.
    Joyce, P.
    Mulder, R.
    Luty, S.
    Frampton, C.
    Kennedy, M.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (04) : 531 - 535
  • [7] Genetic Susceptibility for Bipolar Disorder and Response to Antidepressants in Major Depressive Disorder
    Tansey, Katherine E.
    Guipponi, Michel
    Domenici, Enrico
    Lewis, Glyn
    Malafosse, Alain
    O'Donovan, Michael
    Wendland, Jens R.
    Lewis, Cathryn M.
    McGuffin, Peter
    Uher, Rudolf
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2014, 165 (01) : 77 - 83
  • [8] Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis
    van den Broek, W. W.
    Mulder, P. G. H.
    van Os, E.
    Birkenhager, T. K.
    Pluijms, E.
    Bruijn, J. A.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (06) : 708 - 713
  • [9] Psychopharmacology Algorithms for Major Depressive Disorder: Current Status
    Sanches, Marsal
    Quevedo, Joao
    Soares, Jair C.
    MAJOR DEPRESSIVE DISORDER: RETHINKING AND UNDERSTANDING RECENT DISCOVERIES, 2021, 1305 : 429 - 445
  • [10] Genetic disposition to inflammation and response to antidepressants in major depressive disorder
    Zwicker, Alyson
    Fabbri, Chiara
    Rietschel, Marcella
    Hauser, Joanna
    Mors, Ole
    Maier, Wolfgang
    Zobel, Astrid
    Farmer, Anne
    Aitchison, Katherine J.
    McGuffin, Peter
    Lewis, Cathryn M.
    Uher, Rudolf
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 105 : 17 - 22